UPDATE 3-Merck gives cautious 2016 outlook as sales of top medicines lag

Feb 3 (Reuters) - Merck & Co Inc on Wednesday issued a cautious 2016 outlook and reported disappointing fourth-quarter sales of its Januvia diabetes treatment and its Remicade arthritis drug, sending...